Machine learning risk stratification to identify people living with HIV at high risk of delayed ART and advanced immunosuppression
A precision public health approach
Bibliographic Data
| ID | 22080072 |
|---|---|
| Authors | Jinling Yin (The Eighth Hospital of Xi'an), Tingting Li (0009-0002-0758-3109, Xi'an Chest Hospital), Juan Jin (0009-0000-1243-8016, The Eighth Hospital of Xi'an), Jie Chen (0000-0002-9254-4413, The Eighth Hospital of Xi'an), Huanhuan Ba (The Eighth Hospital of Xi'an), Yuan Zhang (0000-0002-0902-9585, The Eighth Hospital of Xi'an), Jiajia Li (0000-0003-1706-8987, The Eighth Hospital of Xi'an), Huanqing Liu (Northwestern Polytechnical University), Kangxiao Ma (The Eighth Hospital of Xi'an) |
| Year | 2026 |
| Volume | 14 |
| Pages | 1835733-1835733 |
| Publication date | 2026-06-05 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2026.1835733 |
| PMID | 42326917 |
| OpenAlex | W7163702444 |
| Language | EN |
| References cited | 15 |
Background: Late presentation and delayed antiretroviral therapy (ART) initiation among people living with HIV (PLWH) are associated with increased morbidity, mortality, and transmission risk. Identifying individuals at high risk of delayed care or severe immunosuppression (CD4 < 200 cells/μL) could enable targeted interventions. Objective: To develop and validate an artificial intelligence (AI)-based risk stratification tool using routinely collected data to identify PLWH at high risk of delayed ART initiation or advanced immunosuppression. Methods: We conducted a retrospective cohort study using de-identified data from HIV-positive individuals (2016 onward). A composite high-risk outcome was defined as delayed ART initiation or baseline CD4 < 200 cells/μL. Multiple classifiers-including logistic regression, XGBoost, LightGBM, CatBoost, multilayer perceptron, and HistGradientBoosting-were trained with five-fold stratified cross-validation. A stacking ensemble incorporating six base models and a LightGBM meta-learner was evaluated. Discrimination (AUC-ROC, AUC-PR), calibration, and clinical utility (decision curve analysis) were assessed. Results: Among 5,436 eligible participants, 61.2% were high-risk. The stacking ensemble achieved an AUC-ROC of 0.915, AUC-PR of 0.950, accuracy of 0.815, and F1 score of 0.858. At ≥90% sensitivity, precision was 0.810. Calibration was good across deciles; decision curve analysis showed net benefit superior to treat-all or treat-none strategies. Baseline CD4 count, age, and transmission route were the strongest predictors. Conclusion: An AI-based risk stratification tool using routinely collected data can identify PLWH at high risk of delayed ART or advanced immunosuppression with strong performance and clinical utility. Prospective validation and equity assessment are needed before implementation
Clinical decision support system · Cohort · Cohort study · Health care · Logistic regression · Prospective cohort study · Receiver operating characteristic · Risk assessment · Risk Stratification · HIV Research and Treatment · HIV-related health complications and treatments · HIV/AIDS Research and Interventions
| Highly cited | No |
|---|